After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Medical Instruments & Supplies industry segment, falling under the Healthcare sector. The current market capitalization of Biolife Solutions Inc is $1.28B. A total of 0.38 million shares were traded on the day, compared to an average of 386.63K shares.
In the most recent transaction, DuRoss Amy sold 4,523 shares of BLFS for 24.51 per share on Nov 20 ’25. After the transaction, the Director now owns 25,687 company shares. In a previous transaction on Nov 21 ’25, DuRoss Amy sold 1,000 shares at 26.00 per share. BLFS shares that Director owns now total 24,687.
Among the insiders who sold shares, DuRoss Amy disposed of 477 shares on Nov 19 ’25 at a per-share price of $24.50. This resulted in the Director holding 30,210 shares of BLFS after the transaction. In another insider transaction, DE GREEF RODERICK sold 35,417 shares at $26.15 per share on Nov 11 ’25. Company shares held by the President and CEO now total 454,581.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, BLFS has a high of $29.62 and a low of $19.10.
As of this writing, BLFS has an earnings estimate of $0.01 per share for the current quarter. EPS was calculated based on a consensus of 1.0 estimates, with a high estimate of $0.01 per share and a lower estimate of $0.01. The company reported an EPS of -$0.02 in the last quarter
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. BLFS’s latest balance sheet shows that the firm has $69.86M in Cash & Short Term Investments as of fiscal 2021. There were $26.88M in debt and $42.70M in liabilities at the time. Its Book Value Per Share was $7.37, while its Total Shareholder’s Equity was $478.05M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BLFS is Buy with a score of 5.00.
